Αρχική World News Sugar Compound Found in Breast Milk May Help Ease Chemotherapy Side Effects

Sugar Compound Found in Breast Milk May Help Ease Chemotherapy Side Effects

Chemotherapy has a wide range of side effects, including fatigue, hair loss, and brain fog. Fast-growing cells throughout the body are targeted by this treatment, which can in turn damage digestive tract cells, as well. A new study says breast milk could be helpful in minimizing those digestive side effects.

Researchers from Vanderbilt University had been studying how compounds in breast milk can make the gastrointestinal systems of infants healthier than formula does. As they investigated this, they wondered if the same compounds in breast milk could in turn address damage to the digestive system in chemotherapy patients. By using a type of sugar found in the milk, they discovered that it may do just that. The findings can be read in the journal Cellular and Molecular Gastroenterology and Hepatology.

PHOTO: ADOBE STOCK/NIPOL

The particular issue this study aimed to address was inflammation known as mucositis, which destroys epithelial cells. Epithelial cells are tasked with digesting food, absorbing nutrients, protecting against pathogens, and continuous cell renewal and cell death which helps eliminate damaged cells. The destruction of these cells can lead to ulceration in the upper digestive track and the small intestine.

Steven Townsend, research team member and associate professor of chemistry at Vanderbilt, explains, “Intestinal mucositis is a well-kept secret. A vast majority of patients receiving chemotherapy experience inflammation in the gastrointestinal tract lining, but there are no effective treatments for the condition.”

Article continues below

Our Featured Programs

See how we’re making a difference for People, Pets, and the Planet and how you can get involved!

Along with Fang Yan, research professor of pediatrics and cell and development biology at Vanderbilt, Townsend discovered that the breast milk sugar 2′-fucosyllactose helps address the damage caused by mucositis. The team administered the sugar to mice with intestinal mucositis, finding that it prevented the death of epithelial cells. The hope is that this can ultimately be used to help cancer patients struggling with digestive discomfort.

PHOTO: ADOBE STOCK/PANITHAN

Townsend also stresses such a treatment’s safety, explaining, “Babies consume 20-25 grams of these compounds a day from breast milk. There is no toxicity associated with the aspect of breast milk.”

The researchers acknowledged some limitations to the study. One concern is that overuse of breast milk sugars could lead to bacteria that are resistant to the effects of 2′-fucosyllactose in infants. This is because these milk sugars also act as antibiotics. Townsend hopes to minimize this possibility by finding other sugars that can work in the same way. He’ll begin by looking at the other 200 sugar compounds in breast milk.

With further research, there is hope that this treatment could be used for patients living with other conditions, including inflammatory bowel disease.

PHOTO: ADOBE STOCK/WATCHARA

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Despite Proven Safety of HPV Vaccines, More Parents Have Concerns

October 22, 2021, by NCI Staff Credit: National Cancer Institute Despite more than 15 years of consistent evidence that HPV vaccines are safe and effective, a...

FDA Approves Atezolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer

On 15 October 2021, the US Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for adjuvant treatment following resection and platinum-based chemotherapy...

Breast Cancer Survivor Uses Comedy to Spread Awareness and Address Disparities

Suzette Simon lost her mother to breast cancer. In 2020, she learned that she had the disease, as well. Realizing how much harder breast...

Why Wearing Comfortable Clothes During Cancer Treatment Matters

Voices on Cancer is an award-winning Cancer.Net Blog series where advocates share their stories and the lessons they have learned about being a cancer advocate. Cindy Trice is...

Breast cancer surgery: ‘I’m proud of the tattoos inked across my chest’

Wendy had a double mastectomy in 2017 and remained flat. “When the consultant told me, I remember crying and saying that I have 2 young...

EMA Recommends Granting a Marketing Authorisation for Zanubrutinib for the Treatment of Waldenström’s Macroglobulinaemia

On 16 September 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of...